Pharmacology and anti‐addiction effects of the novel κ opioid receptor agonistMesylSalB, a potent and long‐acting analogue of salvinorinA
British Journal of Pharmacology2014Vol. 172(2), pp. 515–531
Citations Over TimeTop 10% of 2014 papers
Bridget Simonson, Aashish S. Morani, Amy Ewald, Leigh C. Walker, Nitin Kumar, Denise S. Simpson, John H. Miller, Thomas E. Prisinzano, Bronwyn M. Kivell
Abstract
This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
Related Papers
- → Agonist‐selective signaling of G protein‐coupled receptor: Mechanisms and implications(2010)69 cited
- → Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor(2021)22 cited
- → Being mindful of seven‐transmembrane receptor ‘guests’ when assessing agonist selectivity(2010)13 cited
- → Analysis of agonist action using the operational model(1988)26 cited
- → Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity(2016)1 cited